欢迎来到天天文库
浏览记录
ID:33273455
大小:383.26 KB
页数:36页
时间:2019-02-23
《十二味地黄汤对高血压患者早期肾损害的临床干预研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、提要目的:观察十二味地黄汤对高血压患者早期肾损害的临床干预研究。方法:根据纳入病例标准,选取60例高血压伴早期肾损害患者,随机分为治疗组和对照组。对照组30例,给予常规西药治疗;治疗组30例,在常规西药治疗基础上加服十二味地黄汤,一日一剂,二次分服,8周后进行临床疗效评定。分别于治疗前、后行血压测量,尿微量蛋白,肾功能等实验室检查,观察患者血压、症状、体征及肾功能水平在治疗前后的变化,从而评判其疗效及安全性。结果:治疗8周后,临床研究显示治疗组在肾功改善积分、中医证候总疗效方面优于对照组(P<0.05);治疗
2、后,治疗组肾功改善改善优于对照组(P<0.05)。结论:十二味地黄汤对高血压患者早期肾损害方面有显著保护作用。关键词十二味地黄汤;高血压患者;肾损害;临床研究ToObservetheClinicalEfficacyofShiErWeiDiHuangDecoctionintheEarlyStageHypertensiveNephropathySpecialty:InternalMedicineofTraditionalChineseMedicineAuthor:SunNingningTutor:Prof.LuX
3、iaohuiAbstractObjective:Toobservetheclinicalefficacyofshierweidihuangdecoctionintheearlystagehypertensivenephropathy.Methods:60casesoftheearlystagehypertensivenephropathywererandomlydividedintotreatmentgroupandcontrolgroup,thetreatmentgroupof30patientstreat
4、edwithroutinetreatmentandshierweidihuangdecoction,andthecontrolgroupof30patientsonlytreatedwithroutinetreatment.Beforetreatment,respectively,underwentbloodpressuremeasurement,urinetraceprotein,andrenalfunctionlaboratorytests,theobservedbloodpressurechanges,
5、symptoms,signsofchangeofthelevelofrenalfunctionbeforeandaftertreatment,inordertojudgetheirefficacyandsafety.Results:After4weeksoftreatment,clinicalstudieshaveshowntreatmentgroupimprovedinrenalfunctionpoints,designatethetotaleffectofTCMsyndromethanthecontrol
6、group(P<0.05).Theclinicalstudyshowedthatthetreatmentgroupwasbetterthanthecontrolgroupintheearlystagehypertensivenephropathy.Conclusion:thetreatmentofshierweidihuangdecoctionhasabettercurativeeffectfortheearlystagehypertensivenephropathypatientKeywordshypert
7、ensive;shierweidihuangdecoction;Clinicstudy目录引言...............................................................................................................................0临床研究..............................................................................
8、.................................................3一、研究对象及病例来源...................................................................................................3二、病例选择标准................................
此文档下载收益归作者所有